NORTH CHICAGO, Ill., Oct. 20, 2025 /PRNewswire/ -- AbbVie (ABBV) today announced positive topline results from the Phase 3b/4 head-to-head SELECT-SWITCH study evaluating the efficacy and safety of ...
Please provide your email address to receive an email when new articles are posted on . Hadlima was approved as a biosimilar to Humira in 2019. The drug is available in a pre-filled syringe or a ...
German drugmaker Boehringer Ingelheim announced Monday that it launched an interchangeable biosimilar to AbbVie’s (NYSE:ABBV) blockbuster arthritis therapy Humira at an 81% discount to the reference ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback